← All trials
NCT04930679
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 24, 2018
- Primary completion
- Feb 22, 2019
- Completion date
- Feb 22, 2019
- First posted
- Jun 18, 2021
- Last posted
- Jun 18, 2021
- Enrollment
- 14
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hanoi Medical UniversityLead sponsor
- Hanoi Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.